resTORbio Inc. [TORC] is 36.91% higher this YTD. Is it still time to buy?



resTORbio Inc. [NASDAQ: TORC] loss -9.33% or -0.21 points to close at $2.04 with a heavy trading volume of 1379621 shares. It opened the trading session at $2.18, the shares rose to $2.2257 and dropped to $1.9813, the range by which the price of stock traded the whole day. The daily chart for TORC points out that the company has recorded 64.52% gains over the past six months. However, it is still -137.21% lower than its most recent low trading price.

If we look at the average trading volume of 1.30M shares, TORC reached to a volume of 1379621 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Here is what top equities market gurus are saying about resTORbio Inc. [TORC]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TORC shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TORC stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Evercore ISI have made an estimate for resTORbio Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 30, 2020. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on September 09, 2019, representing the official price target for resTORbio Inc. stock.

The Average True Range (ATR) for resTORbio Inc. is set at 0.22 The Price to Book ratio for the last quarter was 0.99, with the Price to Cash per share for the same quarter was set at 2.14.

Trading performance analysis for TORC stock

resTORbio Inc. [TORC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.45. With this latest performance, TORC shares gained by 5.70% in over the last four-week period, additionally plugging by 64.52% over the last 6 months – not to mention a drop of -77.08% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TORC stock in for the last two-week period is set at 52.06, with the RSI for the last a single of trading hit 46.59, and the three-weeks RSI is set at 54.85 for resTORbio Inc. [TORC]. The present Moving Average for the last 50 days of trading for this stock 1.65, while it was recorded at 2.22 for the last single week of trading, and 3.43 for the last 200 days.

resTORbio Inc. [TORC]: A deeper dive into fundamental analysis

Return on Total Capital for TORC is now -91.94, given the latest momentum, and Return on Invested Capital for the company is -89.01. Return on Equity for this stock declined to -89.01, with Return on Assets sitting at -81.18.

Reflecting on the efficiency of the workforce at the company, resTORbio Inc. [TORC] managed to generate an average of -$4,596,611 per employee.resTORbio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 30.20 and a Current Ratio set at 30.20.

resTORbio Inc. [TORC]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, resTORbio Inc. posted -0.51/share EPS, while the average EPS was predicted by analysts to be reported at -0.39/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -30.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TORC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for resTORbio Inc. go to 29.10%.

An analysis of insider ownership at resTORbio Inc. [TORC]

There are presently around $30 million, or 36.90% of TORC stock, in the hands of institutional investors. The top three institutional holders of TORC stocks are: ORBIMED ADVISORS LLC with ownership of 4,830,387, which is approximately 0% of the company’s market cap and around 11.90% of the total institutional ownership; BLACKROCK INC., holding 1,581,737 shares of the stock with an approximate value of $3.56 million in TORC stocks shares; and BAILLIE GIFFORD & CO, currently with $2.86 million in TORC stock with ownership of nearly 0% of the company’s market capitalization.

Positions in resTORbio Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 32 institutional holders increased their position in resTORbio Inc. [NASDAQ:TORC] by around 1,694,040 shares. Additionally, 23 investors decreased positions by around 6,447,964 shares, while 11 investors held positions by with 5,090,833 shares. The mentioned changes placed institutional holdings at 13,232,837 shares, according to the latest SEC report filing. TORC stock had 14 new institutional investments in for a total of 833,442 shares, while 12 institutional investors sold positions of 4,778,792 shares during the same period.



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam